<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00569504</url>
  </required_header>
  <id_info>
    <org_study_id>snh001</org_study_id>
    <secondary_id>PMSPSTA</secondary_id>
    <nct_id>NCT00569504</nct_id>
  </id_info>
  <brief_title>Prevalence of the Metabolic Syndrome in SPR Taking Antipsychotics</brief_title>
  <official_title>Prevalence of the Metabolic Syndrome in Patients With Schizophrenia Taking Antipsychotics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Korea Otsuka Pharmaceutical Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the cross-sectional prevalence of the metabolic
      syndrome in patients with schizophrenia taking antipsychotics.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Schizophrenic patients taking any kind of antipsychotics for at least 1 year at the Seoul
      National Hospital will be participated in this study.

      we are planning to enroll approximately 1000 patients with schizophrenia.

      For each subject

        -  abdominal circumference

        -  body mass index

        -  lipid profile : TG, HDL-chlo, total chol

        -  systolic/diastolic blood pressure

        -  fasting blood glucose will be measured.

      we will calculate the rates of patients who meet the criteria for the Metabolic syndrome.

        1. Abdominal obesity : absolute criteria

        2. 2 or more of followings

             1. Triglyceride ≥ 150mg/dL or ongoing treatment

             2. HDL-cholesterol ＜ 40mg/dL (men) HDL-cholesterol ＜ 50mg/dL (female) or ongoing
                treatment

             3. Hypertension 130mmHg ≥ systolic 85mmHg ≥ diastolic or ongoing treatment

             4. FBS ≥ 100mg/dL or previous diagnosis of type II DM
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2007</start_date>
  <completion_date type="Anticipated">September 2009</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>metabolic syndrome</measure>
    <time_frame>cross-sectional</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>each factor of metabolic syndrome</measure>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Metabolic Syndrome</condition>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>A, observatoin</arm_group_label>
    <description>inpatients and outpatients in Seoul National Hospital</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood sampling
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        DSM-IV diagnosis of schizophrenia
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients taking a same antipsychotics at least more than one year

          -  schizophrenia or schizoaffective disorder

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jong-il Lee, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Seoul National Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shi Hyun Kang, M.D.</last_name>
    <phone>82-2-2204-0326</phone>
    <email>drshe@hanmail.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>139-757</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shi Hyun Kang, M.D.</last_name>
      <phone>82-2-2204-0326</phone>
      <email>drshe@hanmail.net</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 6, 2007</study_first_submitted>
  <study_first_submitted_qc>December 6, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 7, 2007</study_first_posted>
  <last_update_submitted>June 11, 2009</last_update_submitted>
  <last_update_submitted_qc>June 11, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 12, 2009</last_update_posted>
  <responsible_party>
    <name_title>Shi Hyun Kang</name_title>
    <organization>Seoul National Hospital</organization>
  </responsible_party>
  <keyword>schizophrenia</keyword>
  <keyword>antipsychotics</keyword>
  <keyword>metabolic syndrome</keyword>
  <keyword>prevalence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Schizophrenia</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antipsychotic Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

